A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma
Public ClinicalTrials.gov record NCT01984242. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) Administered as Monotherapy or in Combination With Bevacizumab Versus Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
Study identification
- NCT ID
- NCT01984242
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 305 participants
Conditions and interventions
Conditions
Interventions
- Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody Drug
- Bevacizumab Drug
- Sunitinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 7, 2014
- Primary completion
- Oct 16, 2016
- Completion
- Jan 7, 2019
- Last update posted
- Dec 22, 2019
2014 – 2019
United States locations
- U.S. sites
- 25
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HonorHealth Research Institute - Bisgrove | Scottsdale | Arizona | 85258 | — |
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | — |
| UCLA | Los Angeles | California | 90024 | — |
| University of California | San Francisco | California | 94158 | — |
| Univ Colorado Health Sci Ctr | Aurora | Colorado | 80045 | — |
| Rocky Mountain Cancer Ctr - Denver (Williams) | Denver | Colorado | 80218 | — |
| Yale Uni School of Medicine; Section of Medical Oncology | New Haven | Connecticut | 06510-3289 | — |
| Georgetown U; Lombardi Comp Can | Washington D.C. | District of Columbia | 20016-1468 | — |
| SCRI Florida Cancer Specialists South | Fort Myers | Florida | 33916 | — |
| Mayo Clinic-Jacksonville | Jacksonville | Florida | 32224 | — |
| Florida Cancer Specialist, North Region | St. Petersburg | Florida | 33705 | — |
| The University of Chicago | Chicago | Illinois | 60637 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana Farber Cancer Inst. | Boston | Massachusetts | 02115 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Karmanos Cancer Institute. | Detroit | Michigan | 48201 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89128 | — |
| Memorial Sloan-Kettering | New York | New York | — | — |
| Oncology Hematology Care Inc | Cincinnati | Ohio | 45242 | — |
| Cleveland Clinic Foundation; Taussig Cancer Center | Cleveland | Ohio | 44195 | — |
| Oncology Associates of Oregon, P.C | Eugene | Oregon | 97401 | — |
| Northwest Cancer Specialists, P.C. | Tigard | Oregon | 97223 | — |
| Tennessee Oncology PLLC - Nashville (20th Ave) | Nashville | Tennessee | 37203 | — |
| Vanderbilt Medical Center | Nashville | Tennessee | 37232-7610 | — |
| Texas Oncology-Baylor Sammons Cancer Center | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01984242, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2019 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01984242 live on ClinicalTrials.gov.